Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Jennifer Joy Kordich
Introduction
Jennifer Joy Kordich is a notable inventor based in Sammamish, WA (US). She has made significant contributions to the field of cancer research through her innovative work in antibody development. Her dedication to advancing medical science is evident in her patented inventions.
Latest Patents
Jennifer holds a patent for "Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof." This invention provides fusion proteins expressed by cancer cells, along with antibodies and other antigen-binding agents that specifically bind to these fusion proteins. The patent outlines compositions and methods for using these antibodies and agents to detect, characterize, and treat cancer. This groundbreaking work has the potential to enhance cancer diagnostics and therapies.
Career Highlights
Jennifer Kordich has established herself as a key figure in her field, working at Amgen Inc., a leading biotechnology company. Her role at Amgen allows her to collaborate with other experts and contribute to innovative solutions in healthcare.
Collaborations
Throughout her career, Jennifer has worked alongside talented individuals such as Kim Coign Quon and Gene Cutler. These collaborations have fostered an environment of creativity and innovation, leading to advancements in cancer treatment.
Conclusion
Jennifer Joy Kordich's contributions to cancer research through her patented inventions and collaborations highlight her commitment to improving healthcare. Her work exemplifies the impact of innovation in the fight against cancer.